Table 2.
Characteristics | Patients | Cytoplasmic expression
|
p* | Nuclear expression
|
p* | ||
---|---|---|---|---|---|---|---|
<1.5 | ≥1.5 | <1.5 | ≥1.5 | ||||
Gender | |||||||
Male | 42 | 9 | 21 | 0.9186 | 18 | 12 | 0.1524 |
Female | 51 | 14 | 31 | 34 | 11 | ||
Stage T (male) | |||||||
Non-invasive | 6 | 4 | 1 | 0.0101 | 5 | 0 | 0.0608 |
Invasive | 30 | 4 | 16 | 11 | 9 | ||
Stage T (female) | |||||||
Non-invasive | 15 | 6 | 5 | 0.0418 | 7 | 4 | 0.3421 |
Invasive | 33 | 7 | 25 | 25 | 7 | ||
LN positive (male) | |||||||
No | 27 | 9 | 11 | 0.0112 | 15 | 5 | 0.0177 |
Yes | 15 | 0 | 10 | 3 | 7 | ||
LN positive (female) | |||||||
No | 33 | 10 | 19 | 0.3824 | 22 | 7 | 0.7549 |
Yes | 15 | 3 | 11 | 10 | 4 | ||
Grade (male) | |||||||
Low | 21 | 7 | 7 | 0.0701 | 10 | 4 | 0.232 |
High | 18 | 3 | 13 | 8 | 8 | ||
Grade (female) | |||||||
Low | 39 | 12 | 24 | 0.5196 | 26 | 10 | 0.2981 |
High | 12 | 2 | 7 | 8 | 1 |
p value considered significant at ≤0.05.
Chi square test was employed for determining correlation.